SG Americas Securities, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,180
+39.4%
252,609
+67.1%
0.02%
+108.3%
Q2 2023$1,564
+379.8%
151,134
+403.6%
0.01%
+200.0%
Q1 2023$326
+88.4%
30,008
+94.8%
0.00%
+100.0%
Q4 2022$173
-99.9%
15,407
-43.5%
0.00%
-33.3%
Q3 2022$276,000
+72.5%
27,265
+54.1%
0.00%
+50.0%
Q2 2022$160,000
-33.3%
17,698
-18.5%
0.00%
+100.0%
Q4 2021$240,000
-16.7%
21,711
-44.3%
0.00%0.0%
Q3 2021$288,000
+146.2%
38,968
+384.6%
0.00%0.0%
Q2 2021$117,000
-84.4%
8,042
-81.0%
0.00%
-75.0%
Q4 2020$750,000
+114.9%
42,230
+153.7%
0.00%
+33.3%
Q2 2020$349,000
-46.4%
16,643
-40.9%
0.00%
-50.0%
Q1 2020$651,000
+317.3%
28,178
+366.9%
0.01%
+500.0%
Q4 2019$156,0000.0%6,035
-12.4%
0.00%0.0%
Q1 2019$156,000
+20.0%
6,890
+28.9%
0.00%0.0%
Q1 2018$130,000
-58.1%
5,347
-41.0%
0.00%
-66.7%
Q3 2017$310,000
+31.4%
9,061
+52.8%
0.00%
+50.0%
Q2 2017$236,000
+16.8%
5,931
+8.1%
0.00%0.0%
Q1 2017$202,000
-70.6%
5,488
-74.5%
0.00%
-66.7%
Q4 2016$686,00021,5100.01%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 10,898,879$264,297,00023.51%
Foundation Asset Management, LP 399,537$9,689,0003.59%
Cormorant Asset Management, LP 1,300,000$31,525,0002.35%
Baupost Group 9,309,168$225,747,0002.18%
Old West Investment Management, LLC 109,320$2,651,0001.53%
SENZAR ASSET MANAGEMENT, LLC 187,856$4,555,0001.44%
Chescapmanager LLC 350,631$8,503,0001.27%
Virtus ETF Advisers LLC 32,989$800,0000.69%
Rock Springs Capital Management LP 652,600$15,826,0000.68%
NJ State Employees Deferred Compensation Plan 34,142$828,0000.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders